Household Healthcare Sector

Y-mAbs Therapeutics

Market Cap: US$188.8m

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.

CARGO Therapeutics

Market Cap: US$188.6m

A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

Omeros

Market Cap: US$188.4m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Monash IVF Group

Market Cap: AU$290.3m

Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.

Quanterix

Market Cap: US$186.0m

A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.

scPharmaceuticals

Market Cap: US$185.8m

A pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care.

Electromed

Market Cap: US$184.4m

Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

Kodiak Sciences

Market Cap: US$184.2m

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

Baird Medical Investment Holdings

Market Cap: US$183.2m

Engages in research and development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China.

DiaMedica Therapeutics

Market Cap: US$183.0m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

Eledon Pharmaceuticals

Market Cap: US$182.0m

Operates as a clinical stage biotechnology company.

Pacific Smiles Group

Market Cap: AU$283.7m

Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.

Deltex Medical Group

Market Cap: US$180.6m

Manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, and internationally.

Inhibrx Biosciences

Market Cap: US$180.5m

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

INmune Bio

Market Cap: US$180.3m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

ProQR Therapeutics

Market Cap: US$179.9m

A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

Stereotaxis

Market Cap: US$179.7m

Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

Organigram Global

Market Cap: CA$250.4m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

CVRx

Market Cap: US$178.6m

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.

AVITA Medical

Market Cap: US$178.2m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Puma Biotechnology

Market Cap: US$177.7m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Utah Medical Products

Market Cap: US$176.9m

Provides medical devices for the healthcare industry worldwide.

4D Molecular Therapeutics

Market Cap: US$176.0m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Anika Therapeutics

Market Cap: US$174.4m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Spectral Medical

Market Cap: CA$242.3m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

Tonix Pharmaceuticals Holding

Market Cap: US$171.2m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

Prime Medicine

Market Cap: US$170.6m

A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.

AC Immune

Market Cap: US$169.2m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

Sight Sciences

Market Cap: US$169.1m

An ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases.

Liminatus Pharma

Market Cap: US$167.8m

Operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.

Accuray

Market Cap: US$166.9m

Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

LENSAR

Market Cap: US$166.3m

A commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.

Zentek

Market Cap: CA$231.6m

Engages in the research and development of graphene and related nanomaterials in Canada.

TriSalus Life Sciences

Market Cap: US$165.9m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.

Wellgistics Health

Market Cap: US$165.1m

Engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.

Tiziana Life Sciences

Market Cap: US$165.0m

A biotechnology company, specializes in the development of transformative therapies for neurodegenerative and lung diseases in the United States.